Opthea Limited (OPT.AX)
AUD 0.66
(1.54%)
AUD 0.66
(1.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -191.84 Million USD | 14.14% |
| 2023 | -223.44 Million USD | -67.67% |
| 2022 | -133.27 Million USD | -150.6% |
| 2021 | -53.17 Million USD | -115.3% |
| 2020 | -24.7 Million AUD | 32.64% |
| 2019 | -36.66 Million AUD | -22.6% |
| 2018 | -29.9 Million AUD | -202.24% |
| 2017 | -9.89 Million AUD | -22.4% |
| 2016 | -8.08 Million AUD | -15.45% |
| 2015 | -7 Million AUD | -11.3% |
| 2014 | -6.29 Million AUD | 13.19% |
| 2013 | -7.24 Million AUD | 18.99% |
| 2012 | -8.94 Million AUD | 20.29% |
| 2011 | -11.22 Million AUD | -10.37% |
| 2010 | -10.17 Million AUD | -34.29% |
| 2009 | -7.57 Million AUD | 40.15% |
| 2008 | -12.65 Million AUD | 66.61% |
| 2007 | -37.9 Million AUD | -866.62% |
| 2006 | -3.92 Million AUD | -122.27% |
| 2005 | 17.61 Million AUD | 1072.69% |
| 2004 | -1.81 Million AUD | 39.01% |
| 2003 | -2.96 Million AUD | 8.62% |
| 2002 | -3.24 Million AUD | -290.0% |
| 2001 | -833.01 Thousand AUD | -52.17% |
| 2000 | -547.43 Thousand AUD | 26.19% |
| 1999 | -741.66 Thousand AUD | 39.69% |
| 1998 | -1.22 Million AUD | -16.24% |
| 1997 | -1.05 Million AUD | -8.96% |
| 1996 | -970.98 Thousand AUD | -84.76% |
| 1995 | -525.54 Thousand AUD | -553.86% |
| 1994 | -80.37 Thousand AUD | -7.43% |
| 1993 | -74.81 Thousand AUD | -2.2% |
| 1992 | -73.2 Thousand AUD | 55.39% |
| 1991 | -164.11 Thousand AUD | 74.17% |
| 1990 | -635.35 Thousand AUD | -25.98% |
| 1989 | -504.34 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -143.88 Million USD | 0.0% |
| 2024 FY | -191.84 Million USD | 14.14% |
| 2023 FY | -223.44 Million USD | -67.67% |
| 2023 Q2 | -117.87 Million USD | 0.0% |
| 2023 Q4 | -105.61 Million USD | 0.0% |
| 2022 Q2 | -53.86 Million USD | 0.0% |
| 2022 Q4 | -82.83 Million USD | 0.0% |
| 2022 FY | -133.27 Million USD | -150.6% |
| 2021 FY | -53.17 Million USD | -115.3% |
| 2021 Q2 | -26.37 Million USD | 0.0% |
| 2020 Q4 | -13.11 Million AUD | 0.0% |
| 2020 FY | -24.7 Million AUD | 32.64% |
| 2020 Q2 | -11.57 Million AUD | 0.0% |
| 2019 Q2 | -19.79 Million AUD | 0.0% |
| 2019 Q4 | -17.11 Million AUD | 0.0% |
| 2019 FY | -36.66 Million AUD | -22.6% |
| 2018 Q4 | -16.47 Million AUD | 0.0% |
| 2018 FY | -29.9 Million AUD | -202.24% |
| 2017 FY | -9.89 Million AUD | -22.4% |
| 2017 Q4 | - AUD | 0.0% |
| 2016 FY | -8.08 Million AUD | -15.45% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | -7 Million AUD | -11.3% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | -6.29 Million AUD | 13.19% |
| 2013 Q1 | -1.8 Million AUD | 0.0% |
| 2013 Q3 | -1.57 Million AUD | 0.0% |
| 2013 Q2 | -1.57 Million AUD | 12.8% |
| 2013 FY | -7.24 Million AUD | 18.99% |
| 2013 Q4 | - AUD | 100.0% |
| 2012 Q2 | -1.8 Million AUD | 34.45% |
| 2012 FY | -8.94 Million AUD | 20.29% |
| 2012 Q1 | -2.76 Million AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 Q3 | -1.8 Million AUD | 0.0% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | -11.22 Million AUD | -10.37% |
| 2011 Q3 | -2.76 Million AUD | 0.0% |
| 2011 Q2 | -2.76 Million AUD | -61.48% |
| 2011 Q1 | -1.7 Million AUD | 0.0% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -1.7 Million AUD | 0.0% |
| 2010 Q1 | -2.46 Million AUD | 0.0% |
| 2010 Q2 | -1.7 Million AUD | 30.72% |
| 2010 FY | -10.17 Million AUD | -34.29% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | -7.57 Million AUD | 40.15% |
| 2009 Q3 | -2.46 Million AUD | 0.0% |
| 2009 Q2 | -2.46 Million AUD | -46128.36% |
| 2009 Q1 | 5361.25 AUD | 0.0% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q3 | 5361.25 AUD | 0.0% |
| 2008 Q2 | 5361.25 AUD | 100.13% |
| 2008 Q1 | -4.26 Million AUD | 0.0% |
| 2008 FY | -12.65 Million AUD | 66.61% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 FY | -37.9 Million AUD | -866.62% |
| 2007 Q1 | -1.19 Million AUD | 0.0% |
| 2007 Q2 | -4.26 Million AUD | -257.31% |
| 2007 Q3 | -4.26 Million AUD | 0.0% |
| 2006 Q3 | -1.19 Million AUD | 0.0% |
| 2006 FY | -3.92 Million AUD | -122.27% |
| 2006 Q1 | 5.5 Million AUD | 0.0% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q2 | -1.19 Million AUD | -121.71% |
| 2005 FY | 17.61 Million AUD | 1072.69% |
| 2005 Q1 | -637.88 Thousand AUD | 0.0% |
| 2005 Q2 | 5.5 Million AUD | 962.57% |
| 2005 Q3 | 5.5 Million AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 Q3 | -637.88 Thousand AUD | 0.0% |
| 2004 FY | -1.81 Million AUD | 39.01% |
| 2004 Q4 | - AUD | 100.0% |
| 2004 Q2 | -637.88 Thousand AUD | 42.09% |
| 2004 Q1 | -1.1 Million AUD | 0.0% |
| 2003 Q2 | -1.1 Million AUD | 61.64% |
| 2003 Q3 | -1.1 Million AUD | 0.0% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 FY | -2.96 Million AUD | 8.62% |
| 2003 Q1 | -2.87 Million AUD | 0.0% |
| 2002 Q2 | -2.87 Million AUD | -638.87% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 Q3 | -2.87 Million AUD | 0.0% |
| 2002 FY | -3.24 Million AUD | -290.0% |
| 2002 Q1 | -388.6 Thousand AUD | 0.0% |
| 2001 FY | -833.01 Thousand AUD | -52.17% |
| 2001 Q2 | -388.6 Thousand AUD | -163.53% |
| 2001 Q1 | 611.68 Thousand AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q3 | -388.6 Thousand AUD | 0.0% |
| 2000 Q2 | 611.68 Thousand AUD | -48.39% |
| 2000 Q1 | 1.18 Million AUD | 0.0% |
| 2000 FY | -547.43 Thousand AUD | 26.19% |
| 2000 Q4 | - AUD | -100.0% |
| 2000 Q3 | 611.68 Thousand AUD | 0.0% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 FY | -741.66 Thousand AUD | 39.69% |
| 1999 Q3 | 1.18 Million AUD | 0.0% |
| 1999 Q2 | 1.18 Million AUD | 339.3% |
| 1999 Q1 | -495.25 Thousand AUD | 0.0% |
| 1998 Q1 | -349.52 Thousand AUD | 0.0% |
| 1998 Q2 | -495.25 Thousand AUD | -41.69% |
| 1998 Q4 | -495.25 Thousand AUD | 0.0% |
| 1998 Q3 | -495.25 Thousand AUD | 0.0% |
| 1998 FY | -1.22 Million AUD | -16.24% |
| 1997 FY | -1.05 Million AUD | -8.96% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 Q2 | -349.52 Thousand AUD | -28.5% |
| 1997 Q3 | -349.52 Thousand AUD | 0.0% |
| 1997 Q1 | -272 Thousand AUD | 0.0% |
| 1996 Q2 | -272 Thousand AUD | -64.1% |
| 1996 Q4 | -272 Thousand AUD | 0.0% |
| 1996 FY | -970.98 Thousand AUD | -84.76% |
| 1996 Q1 | -165.75 Thousand AUD | 0.0% |
| 1996 Q3 | -272 Thousand AUD | 0.0% |
| 1995 FY | -525.54 Thousand AUD | -553.86% |
| 1995 Q3 | -165.75 Thousand AUD | 0.0% |
| 1995 Q4 | -165.75 Thousand AUD | 0.0% |
| 1995 Q2 | -165.75 Thousand AUD | -1005.0% |
| 1995 Q1 | -15 Thousand AUD | 0.0% |
| 1994 Q2 | -15 Thousand AUD | 88.24% |
| 1994 FY | -80.37 Thousand AUD | -7.43% |
| 1994 Q1 | -127.5 Thousand AUD | 0.0% |
| 1994 Q3 | -15 Thousand AUD | 0.0% |
| 1994 Q4 | -15 Thousand AUD | 0.0% |
| 1993 Q2 | -127.5 Thousand AUD | -553.85% |
| 1993 Q1 | -19.5 Thousand AUD | 0.0% |
| 1993 FY | -74.81 Thousand AUD | -2.2% |
| 1993 Q4 | -127.5 Thousand AUD | 0.0% |
| 1993 Q3 | -127.5 Thousand AUD | 0.0% |
| 1992 Q2 | -19.5 Thousand AUD | 55.17% |
| 1992 Q4 | -19.5 Thousand AUD | 0.0% |
| 1992 FY | -73.2 Thousand AUD | 55.39% |
| 1992 Q1 | -43.5 Thousand AUD | 0.0% |
| 1992 Q3 | -19.5 Thousand AUD | 0.0% |
| 1991 Q3 | -43.5 Thousand AUD | 0.0% |
| 1991 FY | -164.11 Thousand AUD | 74.17% |
| 1991 Q1 | -154 Thousand AUD | 0.0% |
| 1991 Q2 | -43.5 Thousand AUD | 71.75% |
| 1991 Q4 | -43.5 Thousand AUD | 0.0% |
| 1990 FY | -635.35 Thousand AUD | -25.98% |
| 1990 Q1 | -133.5 Thousand AUD | 0.0% |
| 1990 Q3 | -154 Thousand AUD | 0.0% |
| 1990 Q2 | -154 Thousand AUD | -15.36% |
| 1990 Q4 | -154 Thousand AUD | 0.0% |
| 1989 Q4 | -133.5 Thousand AUD | 0.0% |
| 1989 FY | -504.34 Thousand AUD | 0.0% |
| 1989 Q2 | -133.5 Thousand AUD | 0.0% |
| 1989 Q3 | -133.5 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 2074.389% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -13047.775% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -3130.638% |
| Biome Australia Limited | -1.91 Million AUD | -9927.113% |
| Patrys Limited | -3.53 Million AUD | -5320.588% |
| Orthocell Limited | -11.68 Million AUD | -1542.332% |
| Imugene Limited | -140.93 Million AUD | -36.126% |
| Noxopharm Limited | -7.53 Million AUD | -2446.021% |
| PYC Therapeutics Limited | -38.85 Million AUD | -393.712% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -1458.471% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -2569.518% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -2552.858% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -2078.07% |
| CSL Limited | 5.64 Billion AUD | 103.396% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -2567.058% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -6164.328% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 490.335% |
| Starpharma Holdings Limited | -15.15 Million AUD | -1165.537% |
| Nanollose Limited | -1.24 Million AUD | -15249.568% |
| Memphasys Limited | -2.7 Million AUD | -6994.776% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -8891.39% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -9228.331% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -4235.456% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | -1205.065% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -6575.621% |
| Race Oncology Limited | -13.38 Million AUD | -1333.742% |
| Nyrada Inc. | -4.56 Million AUD | -4106.773% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | -665.54% |
| PharmAust Limited | -6.65 Million AUD | -2781.114% |
| Immutep Limited | -44.93 Million AUD | -326.915% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | -328.214% |
| Alterity Therapeutics Limited | -19.6 Million AUD | -878.704% |
| BTC Health Limited | 1.05 Million AUD | 18279.2% |
| Acrux Limited | -9.83 Million AUD | -1850.811% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 184.9% |
| Biotron Limited | -5.15 Million AUD | -3624.256% |
| Tissue Repair Ltd | -4.87 Million AUD | -3834.468% |
| AdAlta Limited | -5.26 Million AUD | -3546.096% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | -306.362% |
| Hexima Limited | -1 Million AUD | -18917.867% |
| AnteoTech Limited | -11.72 Million AUD | -1535.962% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | -194.634% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | -769.986% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -4080.319% |
| Actinogen Medical Limited | -12.83 Million AUD | -1394.22% |
| Immuron Limited | -5.8 Million AUD | -3206.996% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -3282.751% |